|
TAF1A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.655200E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.997960E-02 |
| Normal-vs-Stage2 |
3.073800E-01 |
| Normal-vs-Stage3 |
1.083650E-03 |
| Normal-vs-Stage4 |
6.837700E-02 |
| Stage1-vs-Stage2 |
4.361400E-01 |
| Stage1-vs-Stage3 |
7.214300E-02 |
| Stage1-vs-Stage4 |
9.448600E-01 |
| Stage2-vs-Stage3 |
6.904000E-02 |
| Stage2-vs-Stage4 |
5.231600E-01 |
| Stage3-vs-Stage4 |
2.172400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.676150E-02 |
| Normal-vs-AfricanAmerican |
4.385200E-04 |
| Normal-vs-Asian |
3.166800E-01 |
| Caucasian-vs-AfricanAmerican |
2.288200E-02 |
| Caucasian-vs-Asian |
6.440500E-02 |
| AfricanAmerican-vs-Asian |
3.304500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.464500E-03 |
| Normal-vs-Female |
3.231600E-02 |
| Male-vs-Female |
4.691000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.508600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.673890E-02 |
| Normal-vs-Age(61-80Yrs) |
1.606250E-02 |
| Normal-vs-Age(81-100Yrs) |
1.246200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.256400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.016200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.124800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.338400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.275400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.526600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.715400E-01 |
| Normal-vs-Grade 2 |
4.781900E-02 |
| Normal-vs-Grade 3 |
5.564500E-04 |
| Normal-vs-Grade 4 |
1.264790E-01 |
| Grade 1-vs-Grade 2 |
4.919000E-01 |
| Grade 1-vs-Grade 3 |
1.433960E-01 |
| Grade 1-vs-Grade 4 |
5.554000E-01 |
| Grade 2-vs-Grade 3 |
5.745700E-02 |
| Grade 2-vs-Grade 4 |
9.126000E-01 |
| Grade 3-vs-Grade 4 |
3.168000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.643190E-01 |
| Normal-vs-ccB subtype |
1.119890E-02 |
| ccA subtype-vs-ccB subtype |
6.636500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.735500E-03 |
| Normal-vs-N1 |
5.026200E-01 |
| N0-vs-N1 |
1.596190E-01 |
|
|
